Europe Viral Vaccines Market Report 2017

February 2017 | 125 pages | ID: E4A8EE3CE73EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Viral Vaccines

Revenue, means the sales value of Viral Vaccines

This report studies sales (consumption) of Viral Vaccines in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

• GSK
• Merck
• Novartis
• Pfizer
• Sanofi
• Bayer
• Zoetis
• AstraZeneca
• Johnson
• CSL

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Viral Vaccines in these countries, from 2011 to 2021 (forecast), like

• Germany
• France
• UK
• Russia
• Italy
• Spain
• Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Attenuated Vaccine
• Inactivated Vaccine

Split by application, this report focuses on sales, market share and growth rate of Viral Vaccines in each application, can be divided into

• Hospital
• Pharmaceutical Factory
• Research Institute
• Other

Contents

Europe Viral Vaccines Market Report 2017

1 VIRAL VACCINES OVERVIEW

1.1 Product Overview and Scope of Viral Vaccines
1.2 Classification of Viral Vaccines
  1.2.1 Attenuated Vaccine
  1.2.2 Inactivated Vaccine
1.3 Application of Viral Vaccines
  1.3.1 Hospital
  1.3.2 Pharmaceutical Factory
  1.3.3 Research Institute
  1.3.4 Other
1.4 Viral Vaccines Market by Countries
  1.4.1 Germany Status and Prospect (2012-2022)
  1.4.2 France Status and Prospect (2012-2022)
  1.4.3 UK Status and Prospect (2012-2022)
  1.4.4 Russia Status and Prospect (2012-2022)
  1.4.5 Italy Status and Prospect (2012-2022)
  1.4.6 Spain Status and Prospect (2012-2022)
  1.4.7 Benelux Status and Prospect (2012-2022)
1.5 Europe Market Size (Value and Volume) of Viral Vaccines (2012-2022)
  1.5.1 Europe Viral Vaccines Sales and Growth Rate (2012-2022)
  1.5.2 Europe Viral Vaccines Revenue and Growth Rate (2012-2022)

2 EUROPE VIRAL VACCINES BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe Viral Vaccines Market Competition by Manufacturers
  2.1.1 Europe Viral Vaccines Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe Viral Vaccines Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Viral Vaccines (Volume and Value) by Type
  2.2.1 Europe Viral Vaccines Sales and Market Share by Type (2012-2017)
  2.2.2 Europe Viral Vaccines Revenue and Market Share by Type (2012-2017)
2.3 Europe Viral Vaccines (Volume and Value) by Countries
  2.3.1 Europe Viral Vaccines Sales and Market Share by Countries (2012-2017)
  2.3.2 Europe Viral Vaccines Revenue and Market Share by Countries (2012-2017)
2.4 Europe Viral Vaccines (Volume) by Application

3 GERMANY VIRAL VACCINES (VOLUME, VALUE AND SALES PRICE)

3.1 Germany Viral Vaccines Sales and Value (2012-2017)
  3.1.1 Germany Viral Vaccines Sales and Growth Rate (2012-2017)
  3.1.2 Germany Viral Vaccines Revenue and Growth Rate (2012-2017)
  3.1.3 Germany Viral Vaccines Sales Price Trend (2012-2017)
3.2 Germany Viral Vaccines Sales and Market Share by Manufacturers
3.3 Germany Viral Vaccines Sales and Market Share by Type
3.4 Germany Viral Vaccines Sales and Market Share by Application

4 FRANCE VIRAL VACCINES (VOLUME, VALUE AND SALES PRICE)

4.1 France Viral Vaccines Sales and Value (2012-2017)
  4.1.1 France Viral Vaccines Sales and Growth Rate (2012-2017)
  4.1.2 France Viral Vaccines Revenue and Growth Rate (2012-2017)
  4.1.4 France Viral Vaccines Sales Price Trend (2012-2017)
4.2 France Viral Vaccines Sales and Market Share by Manufacturers
4.3 France Viral Vaccines Sales and Market Share by Type
4.4 France Viral Vaccines Sales and Market Share by Application

5 UK VIRAL VACCINES (VOLUME, VALUE AND SALES PRICE)

5.1 UK Viral Vaccines Sales and Value (2012-2017)
  5.1.1 UK Viral Vaccines Sales and Growth Rate (2012-2017)
  5.1.2 UK Viral Vaccines Revenue and Growth Rate (2012-2017)
  5.1.5 UK Viral Vaccines Sales Price Trend (2012-2017)
5.2 UK Viral Vaccines Sales and Market Share by Manufacturers
5.3 UK Viral Vaccines Sales and Market Share by Type
5.4 UK Viral Vaccines Sales and Market Share by Application

6 RUSSIA VIRAL VACCINES (VOLUME, VALUE AND SALES PRICE)

6.1 Russia Viral Vaccines Sales and Value (2012-2017)
  6.1.1 Russia Viral Vaccines Sales and Growth Rate (2012-2017)
  6.1.2 Russia Viral Vaccines Revenue and Growth Rate (2012-2017)
  6.1.6 Russia Viral Vaccines Sales Price Trend (2012-2017)
6.2 Russia Viral Vaccines Sales and Market Share by Manufacturers
6.3 Russia Viral Vaccines Sales and Market Share by Type
6.4 Russia Viral Vaccines Sales and Market Share by Application

7 ITALY VIRAL VACCINES (VOLUME, VALUE AND SALES PRICE)

7.1 Italy Viral Vaccines Sales and Value (2012-2017)
  7.1.1 Italy Viral Vaccines Sales and Growth Rate (2012-2017)
  7.1.2 Italy Viral Vaccines Revenue and Growth Rate (2012-2017)
  7.1.7 Italy Viral Vaccines Sales Price Trend (2012-2017)
7.2 Italy Viral Vaccines Sales and Market Share by Manufacturers
7.3 Italy Viral Vaccines Sales and Market Share by Type
7.4 Italy Viral Vaccines Sales and Market Share by Application

8 SPAIN VIRAL VACCINES (VOLUME, VALUE AND SALES PRICE)

8.1 Spain Viral Vaccines Sales and Value (2012-2017)
  8.1.1 Spain Viral Vaccines Sales and Growth Rate (2012-2017)
  8.1.2 Spain Viral Vaccines Revenue and Growth Rate (2012-2017)
  8.1.8 Spain Viral Vaccines Sales Price Trend (2012-2017)
8.2 Spain Viral Vaccines Sales and Market Share by Manufacturers
8.3 Spain Viral Vaccines Sales and Market Share by Type
8.4 Spain Viral Vaccines Sales and Market Share by Application

9 BENELUX VIRAL VACCINES (VOLUME, VALUE AND SALES PRICE)

9.1 Benelux Viral Vaccines Sales and Value (2012-2017)
  9.1.1 Benelux Viral Vaccines Sales and Growth Rate (2012-2017)
  9.1.2 Benelux Viral Vaccines Revenue and Growth Rate (2012-2017)
  9.1.9 Benelux Viral Vaccines Sales Price Trend (2012-2017)
9.2 Benelux Viral Vaccines Sales and Market Share by Manufacturers
9.3 Benelux Viral Vaccines Sales and Market Share by Type
9.4 Benelux Viral Vaccines Sales and Market Share by Application

10 EUROPE VIRAL VACCINES MANUFACTURERS ANALYSIS

10.1 GSK
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Viral Vaccines Product Type, Application and Specification
    10.1.2.1 Attenuated Vaccine
    10.1.2.2 Inactivated Vaccine
  10.1.3 GSK Viral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Main Business/Business Overview
10.2 Merck
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Viral Vaccines Product Type, Application and Specification
    10.2.2.1 Attenuated Vaccine
    10.2.2.2 Inactivated Vaccine
  10.2.3 Merck Viral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Main Business/Business Overview
10.3 Novartis
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Viral Vaccines Product Type, Application and Specification
    10.3.2.1 Attenuated Vaccine
    10.3.2.2 Inactivated Vaccine
  10.3.3 Novartis Viral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Main Business/Business Overview
10.4 Pfizer
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Viral Vaccines Product Type, Application and Specification
    10.4.2.1 Attenuated Vaccine
    10.4.2.2 Inactivated Vaccine
  10.4.3 Pfizer Viral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Main Business/Business Overview
10.5 Sanofi
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Viral Vaccines Product Type, Application and Specification
    10.5.2.1 Attenuated Vaccine
    10.5.2.2 Inactivated Vaccine
  10.5.3 Sanofi Viral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Main Business/Business Overview
10.6 Bayer
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Viral Vaccines Product Type, Application and Specification
    10.6.2.1 Attenuated Vaccine
    10.6.2.2 Inactivated Vaccine
  10.6.3 Bayer Viral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Main Business/Business Overview
10.7 Zoetis
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Viral Vaccines Product Type, Application and Specification
    10.7.2.1 Attenuated Vaccine
    10.7.2.2 Inactivated Vaccine
  10.7.3 Zoetis Viral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Main Business/Business Overview
10.8 AstraZeneca
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Viral Vaccines Product Type, Application and Specification
    10.8.2.1 Attenuated Vaccine
    10.8.2.2 Inactivated Vaccine
  10.8.3 AstraZeneca Viral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Main Business/Business Overview
10.9 Johnson
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Viral Vaccines Product Type, Application and Specification
    10.9.2.1 Attenuated Vaccine
    10.9.2.2 Inactivated Vaccine
  10.9.3 Johnson Viral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Main Business/Business Overview
10.10 CSL
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Viral Vaccines Product Type, Application and Specification
    10.10.2.1 Attenuated Vaccine
    10.10.2.2 Inactivated Vaccine
  10.10.3 CSL Viral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  10.10.4 Main Business/Business Overview

11 VIRAL VACCINES MANUFACTURING COST ANALYSIS

11.1 Viral Vaccines Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Viral Vaccines

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Viral Vaccines Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Viral Vaccines Major Manufacturers in 2015
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 EUROPE VIRAL VACCINES MARKET FORECAST (2017-2022)

14.1 Germany Viral Vaccines Sales Forecast (2017-2022)
14.2 France Viral Vaccines Sales Forecast (2017-2022)
14.3 UK Viral Vaccines Sales Forecast (2017-2022)
14.4 Russia Viral Vaccines Sales Forecast (2017-2022)
14.5 Italy Viral Vaccines Sales Forecast (2017-2022)
14.6 Spain Viral Vaccines Sales Forecast (2017-2022)
14.7 Benelux Viral Vaccines Sales Forecast (2017-2022)
14.8 Europe Viral Vaccines Sales Forecast by Type (2017-2022)
14.9 Europe Viral Vaccines Sales Forecast by Application (2017-2022)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Viral Vaccines
Table Classification of Viral Vaccines
Figure Europe Sales Market Share of Viral Vaccines by Type in 2015
Figure Attenuated Vaccine Picture
Figure Inactivated Vaccine Picture
Table Application of Viral Vaccines
Figure Europe Sales Market Share of Viral Vaccines by Application in 2015
Figure Hospital Examples
Figure Pharmaceutical Factory Examples
Figure Research Institute Examples
Figure Other Examples
Figure Germany Viral Vaccines Revenue and Growth Rate (2012-2022)
Figure France Viral Vaccines Revenue and Growth Rate (2012-2022)
Figure UK Viral Vaccines Revenue and Growth Rate (2012-2022)
Figure Russia Viral Vaccines Revenue and Growth Rate (2012-2022)
Figure Italy Viral Vaccines Revenue and Growth Rate (2012-2022)
Figure Spain Viral Vaccines Revenue and Growth Rate (2012-2022)
Figure Benelux Viral Vaccines Revenue and Growth Rate (2012-2022)
Figure Europe Viral Vaccines Sales and Growth Rate (2012-2022)
Figure Europe Viral Vaccines Revenue and Growth Rate (2012-2022)
Table Europe Viral Vaccines Sales of Key Manufacturers (2015 and 2016)
Table Europe Viral Vaccines Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Viral Vaccines Sales Share by Manufacturers
Figure 2016 Viral Vaccines Sales Share by Manufacturers
Table Europe Viral Vaccines Revenue by Manufacturers (2015 and 2016)
Table Europe Viral Vaccines Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Viral Vaccines Revenue Share by Manufacturers
Table 2016 Europe Viral Vaccines Revenue Share by Manufacturers
Table Europe Viral Vaccines Sales and Market Share by Type (2012-2017)
Table Europe Viral Vaccines Sales Share by Type (2012-2017)
Figure Sales Market Share of Viral Vaccines by Type (2012-2017)
Figure Europe Viral Vaccines Sales Growth Rate by Type (2012-2017)
Table Europe Viral Vaccines Revenue and Market Share by Type (2012-2017)
Table Europe Viral Vaccines Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Viral Vaccines by Type (2012-2017)
Figure Europe Viral Vaccines Revenue Growth Rate by Type (2012-2017)
Table Europe Viral Vaccines Sales and Market Share by Countries (2012-2017)
Table Europe Viral Vaccines Sales Share by Countries (2012-2017)
Figure Sales Market Share of Viral Vaccines by Countries (2012-2017)
Table Europe Viral Vaccines Revenue and Market Share by Countries (2012-2017)
Table Europe Viral Vaccines Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of Viral Vaccines by Countries (2012-2017)
Table Europe Viral Vaccines Sales and Market Share by Application (2012-2017)
Table Europe Viral Vaccines Sales Share by Application (2012-2017)
Figure Sales Market Share of Viral Vaccines by Application (2012-2017)
Figure Germany Viral Vaccines Sales and Growth Rate (2012-2017)
Figure Germany Viral Vaccines Revenue and Growth Rate (2012-2017)
Figure Germany Viral Vaccines Sales Price Trend (2012-2017)
Table Germany Viral Vaccines Sales by Manufacturers (2015 and 2016)
Table Germany Viral Vaccines Market Share by Manufacturers (2015 and 2016)
Table Germany Viral Vaccines Sales by Type (2015 and 2016)
Table Germany Viral Vaccines Market Share by Type (2015 and 2016)
Table Germany Viral Vaccines Sales by Application (2015 and 2016)
Table Germany Viral Vaccines Market Share by Application (2015 and 2016)
Figure France Viral Vaccines Sales and Growth Rate (2012-2017)
Figure France Viral Vaccines Revenue and Growth Rate (2012-2017)
Figure France Viral Vaccines Sales Price Trend (2012-2017)
Table France Viral Vaccines Sales by Manufacturers (2015 and 2016)
Table France Viral Vaccines Market Share by Manufacturers (2015 and 2016)
Table France Viral Vaccines Sales by Type (2015 and 2016)
Table France Viral Vaccines Market Share by Type (2015 and 2016)
Table France Viral Vaccines Sales by Application (2015 and 2016)
Table France Viral Vaccines Market Share by Application (2015 and 2016)
Figure UK Viral Vaccines Sales and Growth Rate (2012-2017)
Figure UK Viral Vaccines Revenue and Growth Rate (2012-2017)
Figure UK Viral Vaccines Sales Price Trend (2012-2017)
Table UK Viral Vaccines Sales by Manufacturers (2015 and 2016)
Table UK Viral Vaccines Market Share by Manufacturers (2015 and 2016)
Table UK Viral Vaccines Sales by Type (2015 and 2016)
Table UK Viral Vaccines Market Share by Type (2015 and 2016)
Table UK Viral Vaccines Sales by Application (2015 and 2016)
Table UK Viral Vaccines Market Share by Application (2015 and 2016)
Figure Russia Viral Vaccines Sales and Growth Rate (2012-2017)
Figure Russia Viral Vaccines Revenue and Growth Rate (2012-2017)
Figure Russia Viral Vaccines Sales Price Trend (2012-2017)
Table Russia Viral Vaccines Sales by Manufacturers (2015 and 2016)
Table Russia Viral Vaccines Market Share by Manufacturers (2015 and 2016)
Table Russia Viral Vaccines Sales by Type (2015 and 2016)
Table Russia Viral Vaccines Market Share by Type (2015 and 2016)
Table Russia Viral Vaccines Sales by Application (2015 and 2016)
Table Russia Viral Vaccines Market Share by Application (2015 and 2016)
Figure Italy Viral Vaccines Sales and Growth Rate (2012-2017)
Figure Italy Viral Vaccines Revenue and Growth Rate (2012-2017)
Figure Italy Viral Vaccines Sales Price Trend (2012-2017)
Table Italy Viral Vaccines Sales by Manufacturers (2015 and 2016)
Table Italy Viral Vaccines Market Share by Manufacturers (2015 and 2016)
Table Italy Viral Vaccines Sales by Type (2015 and 2016)
Table Italy Viral Vaccines Market Share by Type (2015 and 2016)
Table Italy Viral Vaccines Sales by Application (2015 and 2016)
Table Italy Viral Vaccines Market Share by Application (2015 and 2016)
Figure Spain Viral Vaccines Sales and Growth Rate (2012-2017)
Figure Spain Viral Vaccines Revenue and Growth Rate (2012-2017)
Figure Spain Viral Vaccines Sales Price Trend (2012-2017)
Table Spain Viral Vaccines Sales by Manufacturers (2015 and 2016)
Table Spain Viral Vaccines Market Share by Manufacturers (2015 and 2016)
Table Spain Viral Vaccines Sales by Type (2015 and 2016)
Table Spain Viral Vaccines Market Share by Type (2015 and 2016)
Table Spain Viral Vaccines Sales by Application (2015 and 2016)
Table Spain Viral Vaccines Market Share by Application (2015 and 2016)
Figure Benelux Viral Vaccines Sales and Growth Rate (2012-2017)
Figure Benelux Viral Vaccines Revenue and Growth Rate (2012-2017)
Figure Benelux Viral Vaccines Sales Price Trend (2012-2017)
Table Benelux Viral Vaccines Sales by Manufacturers (2015 and 2016)
Table Benelux Viral Vaccines Market Share by Manufacturers (2015 and 2016)
Table Benelux Viral Vaccines Sales by Type (2015 and 2016)
Table Benelux Viral Vaccines Market Share by Type (2015 and 2016)
Table Benelux Viral Vaccines Sales by Application (2015 and 2016)
Table Benelux Viral Vaccines Market Share by Application (2015 and 2016)
Table Viral Vaccines Basic Information List
Table GSK Viral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure GSK Viral Vaccines Sales Market Share (2012-2017)
Table Merck Basic Information List
Table Merck Viral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Table Merck Viral Vaccines Sales Market Share (2012-2017)
Table Novartis Basic Information List
Table Novartis Viral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Table Novartis Viral Vaccines Sales Market Share (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Viral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Viral Vaccines Sales Market Share (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Viral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Table Sanofi Viral Vaccines Sales Market Share (2012-2017)
Table Bayer Basic Information List
Table Bayer Viral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Table Bayer Viral Vaccines Sales Market Share (2012-2017)
Table Zoetis Basic Information List
Table Zoetis Viral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Table Zoetis Viral Vaccines Sales Market Share (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Viral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Table AstraZeneca Viral Vaccines Sales Market Share (2012-2017)
Table Johnson Basic Information List
Table Johnson Viral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Table Johnson Viral Vaccines Sales Market Share (2012-2017)
Table CSL Basic Information List
Table CSL Viral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Table CSL Viral Vaccines Sales Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Viral Vaccines
Figure Manufacturing Process Analysis of Viral Vaccines
Figure Viral Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Viral Vaccines Major Manufacturers in 2015
Table Major Buyers of Viral Vaccines
Table Distributors/Traders List
Figure Germany Viral Vaccines Sales and Growth Rate Forecast (2017-2022)
Figure Germany Viral Vaccines Revenue and Growth Rate Forecast (2017-2022)
Figure France Viral Vaccines Sales and Growth Rate Forecast (2017-2022)
Figure France Viral Vaccines Revenue and Growth Rate Forecast (2017-2022)
Figure UK Viral Vaccines Sales and Growth Rate Forecast (2017-2022)
Figure UK Viral Vaccines Revenue and Growth Rate Forecast (2017-2022)
Figure Russia Viral Vaccines Sales and Growth Rate Forecast (2017-2022)
Figure Russia Viral Vaccines Revenue and Growth Rate Forecast (2017-2022)
Figure Italy Viral Vaccines Sales and Growth Rate Forecast (2017-2022)
Figure Italy Viral Vaccines Revenue and Growth Rate Forecast (2017-2022)
Figure Spain Viral Vaccines Sales and Growth Rate Forecast (2017-2022)
Figure Spain Viral Vaccines Revenue and Growth Rate Forecast (2017-2022)
Figure Benelux Viral Vaccines Sales and Growth Rate Forecast (2017-2022)
Figure Benelux Viral Vaccines Revenue and Growth Rate Forecast (2017-2022)
Table Europe Viral Vaccines Sales Forecast by Type (2017-2022)
Table Europe Viral Vaccines Sales Forecast by Application (2017-2022)